Delivery Order SPE2DB22D2206-SPE2DB25FGV72

Award Date 5/5/25
Potential Completion Date 5/6/25
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,869.60, is for the supply of Vigamox 0.5% eye drops, a prescription ophthalmic medication. The contract has an ultimate completion date of March 28, 2025 and is a Firm Fixed Price arrangement. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,398.33, is for the delivery of Vigamox 0.5% eye drops (3 ml) to support federal medical procurement needs. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,349.48 firm fixed-price contract is for the supply of Vigamox 0.5% eye drops, a medication used to treat bacterial eye infections. The contract has an ultimate completion date of April 19, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vigamox 0.5% eye drops. The contract has a firm-fixed price of $10,031.27 and a performance period through April 4, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,784.03, is for the supply of VIGAMOX 0.5% eye drops. The delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VIGAMOX 0.5% eye drops, a specialty pharmaceutical product. The contract has a firm fixed price of $2,482.87 and runs through September 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and spanning through November 2026. The IDC...
This is a $3,024.97 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VIGAMOX 0.5% eye drops, a pharmaceutical product, with a performance period through May 13, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the procurement of VIGAMOX 0.5% eye drops, a medical product used in the treatment of various eye conditions. The contract has a ceiling value of $2,728.56 and a performance period through May 1, 2023. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a $2,681.72 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VIGAMOX 0.5% eye drops, a prescription ophthalmic medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIGAMOX 0.5% eye drops. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,624.85 and an ultimate completion date of February 3, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGV72
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,637.74, is for the supply of Vigamox 0.5% eye drops, a prescription medication. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition.

The contract is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, designated as SPE2DX, which is a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and has a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/4/25, 9:56 AM